AALL1331, Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
AALL1331, Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
- Recruiting participants (Starts Jan. 19, 2015)
- Not accepting healthy volunteers
- UTSW Principal Investigator: Tamra Lynn Slone
summary
See protocol/CiRB application
eligibility
See protocol